CARE Ratings Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

Quality Assessment: Consistent Profitability and Institutional Confidence

CARE Ratings has demonstrated robust quality metrics, particularly through its consistent profitability track record. The company has reported positive results for 11 consecutive quarters, with the latest Q4 FY25-26 figures showing a Profit Before Tax (PBT) excluding other income of ₹56.30 crores, marking a growth rate of 28.77%. Net Profit After Tax (PAT) for the quarter stood at ₹52.83 crores, up 24.0% year-on-year. This steady earnings momentum underscores operational resilience in the capital markets sector.

Moreover, CARE Ratings is net-debt free, a significant quality indicator that reduces financial risk and enhances balance sheet strength. Institutional investors hold a substantial 54.63% stake, reflecting strong confidence from sophisticated market participants who typically conduct rigorous fundamental analysis. This institutional backing adds credibility to the company’s quality profile and supports the upgrade from a previous Sell rating.

Valuation: Premium Pricing Amidst Moderate Growth

Despite the positive earnings trajectory, CARE Ratings carries a valuation premium that tempers enthusiasm. The company’s Return on Equity (ROE) stands at a healthy 17.7%, yet it trades at a Price to Book (P/B) ratio of 6, which is considered very expensive relative to its peers. This elevated valuation suggests that the market has priced in expectations of sustained growth and profitability.

Over the past year, the stock has delivered a 13.59% return, while profits have increased by 24.7%, resulting in a Price/Earnings to Growth (PEG) ratio of approximately 1.3. This figure indicates a moderately stretched valuation but not excessively so, given the company’s consistent earnings growth. However, long-term sales growth remains modest, with net sales expanding at an annual rate of 13.75% and operating profit growing at 15.76% over the last five years. Investors should weigh this moderate growth against the premium valuation when considering the stock’s prospects.

Financial Trend: Sustained Growth and Outperformance

CARE Ratings’ financial trend remains positive, supported by consistent quarterly earnings growth and strong returns relative to benchmarks. The company’s stock has outperformed the BSE500 index in each of the last three annual periods, delivering a 13.59% return over the past year compared to the BSE500’s negative 7.29%. Over three and five years, the stock’s cumulative returns have been 160.38% and 234.38%, respectively, vastly exceeding the Sensex’s 21.56% and 54.72% returns for the same periods.

This outperformance is notable given the broader market challenges and reflects the company’s ability to generate shareholder value consistently. However, the company’s long-term sales growth remains moderate, which suggests that while profitability and returns are strong, top-line expansion is less aggressive. Investors should consider this dynamic when evaluating the sustainability of the financial trend.

Technicals: Shift from Mildly Bearish to Sideways Momentum

The most significant driver behind the rating upgrade is the marked improvement in technical indicators. The technical trend has shifted from mildly bearish to sideways, signalling a stabilisation in price movement and reduced downside risk. Key technical metrics present a mixed but improving picture:

• MACD (Moving Average Convergence Divergence) is bullish on the weekly chart but mildly bearish on the monthly, indicating short-term momentum is strengthening.
• RSI (Relative Strength Index) is bearish weekly but neutral monthly, suggesting some short-term caution but no strong negative momentum.
• Bollinger Bands show bullish signals on both weekly and monthly charts, implying price volatility is favouring upward movement.
• Moving averages on the daily chart remain mildly bearish, reflecting some near-term resistance.
• KST (Know Sure Thing) indicator is mildly bullish weekly but mildly bearish monthly, reinforcing the mixed but improving trend.
• Dow Theory signals are mildly bullish on both weekly and monthly timeframes, supporting a positive technical outlook.
• On-Balance Volume (OBV) is mildly bullish weekly, indicating buying pressure, though monthly trends show no clear direction.

These technical signals collectively suggest that while the stock is not in a strong uptrend, it has stabilised from previous bearish tendencies and is poised for potential sideways to positive movement. This technical improvement has been a key factor in the upgrade from Sell to Hold, reflecting reduced risk and improved market sentiment.

Price Performance and Market Context

CARE Ratings’ current market price stands at ₹1,736.75, up from the previous close of ₹1,606.60, representing an intraday gain of 8.1%. The stock’s 52-week high is ₹1,964.80, while the low is ₹1,360.00, indicating a relatively wide trading range but recent strength. Today’s trading range has been between ₹1,695.00 and ₹1,787.10, showing active investor interest and volatility.

Comparatively, the Sensex has underperformed CARE Ratings over multiple time horizons, with the stock delivering positive returns even when the broader market has declined. For example, over the year-to-date period, CARE Ratings has gained 8.49% while the Sensex has fallen 11.53%. This relative strength enhances the stock’s appeal despite valuation concerns.

Outlook and Investor Considerations

The upgrade to Hold reflects a more balanced view of CARE Ratings Ltd, recognising its improved technical stance and solid financial performance while acknowledging valuation challenges. Investors should note the company’s strong institutional ownership and net-debt-free status as positive quality markers. However, the premium valuation and moderate long-term sales growth suggest cautious optimism is warranted.

For investors seeking exposure to the capital markets sector, CARE Ratings offers a blend of consistent profitability and relative market outperformance. The sideways technical trend indicates a period of consolidation, which may precede further gains if earnings momentum continues. Conversely, the elevated Price to Book ratio and mixed technical signals advise careful monitoring of market developments and company fundamentals.

Overall, the Hold rating signals that while the stock is no longer a sell candidate, it may not yet be a compelling buy at current levels. Investors should weigh the company’s strengths against valuation and market conditions to determine appropriate portfolio positioning.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →